Clinical Trials
5 trialsNCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT04195399 2026-04-15
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Children's Oncology Group
Phase 2 Active not recruiting
NCT00068419 2020-02-19
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
Phase 2 Completed
NCT00003019 2014-07-25
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Children's Oncology Group
Phase 2 Completed
NCT00030680 2013-08-27
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed